EBS - Emergent BioSolutions Inc. (EBS) CEO Dan Abdun Nabi on Q3 2018 Results - Earnings Call Transcript
Emergent BioSolutions Inc. (EBS)
Q3 2018 Results Conference Call
November 01, 2018 05:00 PM ET
Executives
Bob Burrows - Vice President of Investor Relations
Dan Abdun Nabi - Chief Executive Officer
Bob Kramer - President and Chief Operating Officer
Rich Lindahl - Chief Financial Officer
Doug White - Senior Vice President, Devices Business Unit Head
Abigail Jenkin - Senior Vice President, Vaccines and Anti-infectives Business Unit Head
Atul Saran - Executive Vice President, Corporate Development and General Counsel
Analysts
Brandon Folkes - Cantor Fitzgerald
Dana Flanders - Goldman Sachs
Boris Peaker - Cowen and Company